Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should Be
NVONovo Nordisk(NVO) The Motley Fool·2024-03-18 02:28

Novo Nordisk - Novo Nordisk是一家丹麦制药巨头，在糖尿病护理领域拥有悠久历史[3] - Novo Nordisk在全球糖尿病市场占有率达到33.8%，持续创新并提交了一种潜在的一周一次胰岛素产品icodec的监管申请[5] - Novo Nordisk在肥胖护理领域也有所作为，其减肥药物Wegovy备受欢迎，公司正在处理供应短缺问题[9][10]